動物用藥品市場規模、佔有率和成長分析：按藥物類型、動物種類、給藥途徑、通路和地區分類－2026-2033年產業預測

2024 年全球動物用藥品市場價值 525.2 億美元，預計到 2025 年將成長至 556.8 億美元，到 2033 年將成長至 888.5 億美元，在預測期（2026-2033 年）內複合年成長率為 6.02%。

全球動物用藥品市場的主要驅動力是人口成長和都市化帶來的動物性蛋白質需求成長，進而推動肉類消費量增加和密集畜牧業發展。這種轉變需要更先進的藥物治療來維持生產效率。該市場涵蓋肉類和寵物，產品包括抗生素、驅蟲藥、疫苗和生物製藥。這些藥物在應對疾病威脅、維護食品安全、保障動物健康和保障經濟穩定方面發揮著至關重要的作用。此外，技術進步提高了疾病管理水平，診斷工具和疫苗技術的改進降低了發病率，提高了生產力，使獸藥的推廣應用更具經濟可行性。同時，寵物飼養量的快速成長和水產養殖業的擴張也催生了對專業治療藥物的需求，進一步推動了市場成長。

全球動物用藥品市場的成長要素

全球動物用藥品市場的主要促進因素之一是動物性蛋白質需求的不斷成長，而這又受到全球人口成長和飲食習慣改變的推動。隨著消費者越來越青睞肉類和乳製品，畜牧養殖戶不得不提高牲畜的健康狀況和生產力。這推動了對動物用藥品（如抗生素、疫苗和驅蟲藥）的需求成長，以改善動物福利並確保食品安全。此外，監管壓力和日益增強的動物福利意識也推動了對創新且永續的動物健康解決方案的需求。

全球動物用藥品市場的限制因素

全球動物用藥品市場的主要限制因素之一是動物用藥品法規環境的嚴格性。新動物用藥品的核准流程複雜且耗時，通常需要進行廣泛的安全性和有效性測試。此外，區域監管差異也會為希望進入新市場的製造商帶來挑戰。遵守這些法規需要大量的資金和營運資源，這可能會阻礙中小企業進入市場。此類監管負擔會導致產品上市延遲和成本增加，最終限制獸藥治療方法的多樣性，並阻礙市場成長。

全球動物用藥品市場趨勢

全球動物用藥品市場正經歷著向預防性獸醫學的顯著轉變，這主要得益於人們對動物福利和畜群健康管理的日益重視。這一趨勢凸顯了疫苗接種和全面的寄生蟲預防計劃對於降低疾病風險和提高生產力的重要性。製藥公司正積極響應這一趨勢，拓展產品線，並與養殖戶和獸醫緊密合作，制定全面的健康策略。這種合作不僅加強了客戶關係，還透過長期供應合約和以價值為導向的解決方案促進了永續發展。這些發展對於保障動物福利和生物安全至關重要，並且正在影響市場動態。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球動物用藥品市場規模：依藥物類型分類

• 抗感染藥物
• 驅蟲
• NSAIDs
• 疫苗
• 生物製劑

全球動物用藥品市場規模：依動物類型分類

• 伴侶動物
• 家畜
• 水產養殖
• 家禽

全球動物用藥品市場規模：依給藥途徑分類

• 口服
• 注射藥物
• 外用

全球動物用藥品市場規模：依分銷管道分類

• 動物診所
• 線上
• 寵物店

全球動物用藥品市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Boehringer Ingelheim Animal Health
• Elanco Animal Health
• Merck Animal Health
• Vetoquinol SA
• Virbac SA
• Dechra Pharmaceuticals
• Ceva Animal Health
• Phibro Animal Health
• Norbrook Laboratories
• Huvepharma
• Medela AG
• Neogen Corporation
• Benchmark Animal Health
• Vet-Stem Biopharma

結論與建議

Global Animal Drugs Market size was valued at USD 52.52 Billion in 2024 and is poised to grow from USD 55.68 Billion in 2025 to USD 88.85 Billion by 2033, growing at a CAGR of 6.02% during the forecast period (2026-2033).

The global animal drugs market is primarily driven by the rising demand for animal protein linked to population growth and urbanization, leading to augmented meat consumption and a shift towards intensive farming practices. This transition necessitates enhanced pharmacological treatments to sustain production efficiency. The market encompasses both food-producing animals and pets, featuring antibiotics, anti-parasitics, vaccines, and biological medicines, which play critical roles in maintaining food safety, animal health, and economic stability amid disease threats. Moreover, advancements in technology enhance disease management, with improved diagnostic tools and vaccine technologies reducing morbidity and increasing productivity, making adoption economically viable. Additionally, the surge in pet ownership and growth in aquaculture create opportunities for specialized therapeutics, further driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Drugs Market Segments Analysis

Global animal drugs market is segmented by drug type, animal type, administration, distribution and region. Based on drug type, the market is segmented into Anti-infectives, Anti-parasitics, NSAIDs, Vaccines and Biologics. Based on animal type, the market is segmented into Companion Animals, Livestock, Aquaculture and Poultry. Based on administration, the market is segmented into Oral, Injectable and Topical. Based on distribution, the market is segmented into Veterinary Clinics, Online and Pet Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Drugs Market

One of the key market drivers for the global animal drugs market is the rising demand for animal protein, driven by an increasing global population and changing dietary preferences. As consumers show a preference for meat and dairy products, livestock farmers are compelled to improve the health and productivity of their animals. This has led to a greater need for veterinary medications, including antibiotics, vaccines, and parasiticides, to enhance animal well-being and ensure the safety of food products. Furthermore, regulatory pressures and a growing awareness of animal welfare also propel the demand for innovative and sustainable animal health solutions.

Restraints in the Global Animal Drugs Market

One significant market restraint for the global animal drugs market is the stringent regulatory environment governing veterinary pharmaceuticals. The approval processes for new animal drugs are complex and time-consuming, often requiring extensive safety and efficacy testing. Additionally, variations in regulations across different regions can create challenges for manufacturers aiming to enter new markets. Compliance with these regulations demands substantial financial and operational resources, which may deter smaller companies from participating in the market. This regulatory burden can result in delayed product launches and increased costs, ultimately limiting the variety of available treatments for animal health and impeding market growth.

Market Trends of the Global Animal Drugs Market

The Global Animal Drugs market is experiencing a noteworthy shift towards preventive veterinary medicine, driven by an increasing emphasis on animal welfare and herd health management. This trend highlights the importance of vaccinations and comprehensive parasite prevention programs to mitigate disease risks while enhancing productivity. Pharmaceutical companies are responding by broadening their product offerings, collaborating closely with producers and veterinarians to establish holistic health strategies. This collaborative effort not only strengthens client relationships but also promotes sustainable practices through long-term supply agreements and value-based solutions. Such developments are pivotal in ensuring animal welfare and biosecurity, thereby impacting the overall dynamics of the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Animal Drugs Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Anti-infectives
• Anti-parasitics
• NSAIDs
• Vaccines
• Biologics

Global Animal Drugs Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
• Livestock
• Aquaculture
• Poultry

Global Animal Drugs Market Size by Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical

Global Animal Drugs Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Online
• Pet Stores

Global Animal Drugs Market Size & CAGR (2026-2033)

• North America (Drug Type, Animal Type, Administration, Distribution)
  • US
  • Canada
• Europe (Drug Type, Animal Type, Administration, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Animal Type, Administration, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Animal Type, Administration, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Animal Type, Administration, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medela AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vet-Stem Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations